Complete Filing Data
TREACE MEDICAL CONCEPTS, INC. reported Stockholders Equity of $87.33 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean TREACE MEDICAL CONCEPTS, INC. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Net Income * | -$59.0M | -$55.7M | -$49.5M | -$42.8M | -$20.6M | -$3.7M | -$4.3M |
| Selling And Marketing Expense | $140.9M | $147.6M | $140.9M | $104.6M | $65.4M | $31.7M | $25.8M |
| Revenues | $212.7M | $209.4M | $187.1M | $141.8M | $94.4M | $57.4M | $39.4M |
| Research And Development Expense | $20.3M | $20.6M | $15.4M | $13.6M | $10.2M | $5.8M | $5.1M |
| Other Nonoperating Income Expense | -$4.8M | -$55.0K | $1.9M | -$8.0M | -$4.0M | -$4.5M | -$730.0K |
| Operating Income Loss | -$54.2M | -$55.7M | -$51.4M | -$34.8M | -$16.5M | $855.0K | -$3.5M |
| Operating Expenses | $223.9M | $224.0M | $203.4M | $151.2M | $94.0M | $44.0M | $35.3M |
| Interest Expense | $5.3M | $5.3M | $5.2M | $4.4M | $4.1M | $2.8M | $841.0K |
| Gross Profit | $169.8M | $168.3M | $151.9M | $116.3M | $77.5M | $44.9M | $31.8M |
| General And Administrative Expense | $62.7M | $55.7M | $47.0M | $33.0M | $18.4M | $6.5M | $4.5M |
| Cost Of Goods And Services Sold | $42.9M | $41.1M | $35.2M | $25.5M | $16.9M | $12.5M | $7.6M |
| Comprehensive Income Net Of Tax | -$59.0M | -$55.8M | -$49.3M | -$42.8M | -$20.7M | -$4.3M | |
| Net Income Loss Available To Common Stockholders Basic | -$49.5M | -$42.8M | -$20.7M | -$4.3M | -$4.9M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$16.3M | -$17.4M | -$15.9M | -$15.4M | -$21.2M | -$18.7M | -$17.5M | -$12.3M | -$13.5M | -$12.1M | -$17.2M | -$9.0M | -$6.4M | -$5.1M | -$2.4M | -$2.7M | -$2.0M | -$1.6M |
| Selling And Marketing Expense | $34.4M | $33.1M | $36.1M | $32.8M | $37.7M | $40.3M | $33.5M | $33.8M | $33.7M | $25.6M | $26.6M | $22.3M | $16.0M | $14.0M | $12.1M | $8.1M | $4.8M | $7.3M |
| Revenues | $50.2M | $47.4M | $52.6M | $45.1M | $44.5M | $51.1M | $40.8M | $42.0M | $42.2M | $33.1M | $30.0M | $29.0M | $21.6M | $20.7M | $18.7M | $14.3M | $7.7M | $11.3M |
| Research And Development Expense | $4.7M | $5.5M | $5.6M | $5.0M | $5.2M | $5.3M | $4.4M | $3.5M | $3.4M | $3.8M | $3.0M | $3.1M | $2.5M | $2.4M | $1.9M | $1.5M | $982.0K | $1.4M |
| Other Nonoperating Income Expense | -$612.0K | -$424.0K | -$340.0K | -$226.0K | $176.0K | $292.0K | $297.0K | $781.0K | $322.0K | -$815.0K | -$5.3M | -$940.0K | -$958.0K | -$1.0M | -$1.0M | -$2.6M | -$455.0K | -$408.0K |
| Operating Income Loss | -$15.7M | -$17.0M | -$15.6M | -$15.1M | -$21.4M | -$19.0M | -$17.8M | -$13.1M | -$13.8M | -$11.3M | -$11.9M | -$8.1M | -$5.5M | -$4.1M | -$1.4M | -$63.0K | -$1.5M | -$1.2M |
| Operating Expenses | $55.4M | $54.7M | $57.5M | $51.3M | $57.1M | $59.9M | $50.6M | $47.3M | $47.9M | $38.3M | $36.6M | $32.0M | $22.8M | $20.8M | $16.8M | $11.4M | $7.2M | $10.1M |
| Interest Expense | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | $1.2M | $946.0K | $951.0K | $963.0K | $1.0M | $1.0M | $808.0K | $458.0K | $441.0K |
| Gross Profit | $39.7M | $37.8M | $41.9M | $36.1M | $35.7M | $41.0M | $32.8M | $34.3M | $34.2M | $27.0M | $24.7M | $23.9M | $17.4M | $16.7M | $15.4M | $11.4M | $5.7M | $8.9M |
| General And Administrative Expense | $16.3M | $16.1M | $15.8M | $13.5M | $14.2M | $14.4M | $12.7M | $10.0M | $10.9M | $8.9M | $7.0M | $6.7M | $4.3M | $4.3M | $2.8M | $1.8M | $1.4M | $1.3M |
| Cost Of Goods And Services Sold | $10.5M | $9.6M | $10.7M | $9.0M | $8.8M | $10.1M | $8.0M | $7.7M | $8.0M | $6.1M | $5.3M | $5.1M | $4.2M | $3.9M | $3.3M | $2.9M | $2.1M | $2.4M |
| Comprehensive Income Net Of Tax | -$16.3M | -$17.4M | -$16.0M | -$15.1M | -$21.3M | -$18.8M | -$17.5M | -$12.4M | -$13.5M | -$12.1M | -$17.2M | -$9.0M | ||||||
| Net Income Loss Available To Common Stockholders Basic | -$12.1M | -$17.2M | -$9.0M | -$6.4M | -$5.1M | -$2.6M | -$2.8M | -$2.1M | -$1.8M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $87.3M | $112.9M | $137.9M | $60.5M | $93.1M | $776.0K | $3.2M | $5.9M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $10.7M | $11.4M | $13.0M | $19.5M | $105.8M | $18.1M | $12.1M | |
| Cash And Cash Equivalents At Carrying Value | $10.7M | $11.4M | $13.0M | $19.5M | $105.8M | $18.1M | $12.1M | $1.3M |
| Marketable Securities Unrealized Gain Loss | -$25.0K | -$66.0K | $190.0K | -$27.0K | $0.00 | $0.00 | ||
| Accounts Receivable Net Current | $42.2M | $40.8M | $38.1M | $29.2M | $18.6M | $14.5M | ||
| Retained Earnings Accumulated Deficit | -$249.0M | -$190.0M | -$134.2M | -$84.7M | -$41.9M | -$21.4M | ||
| Property Plant And Equipment Net | $29.8M | $26.0M | $22.3M | $15.3M | $2.8M | $829.0K | ||
| Prepaid Expense And Other Assets Current | $5.5M | $5.7M | $7.9M | $3.6M | $3.0M | $593.0K | ||
| Long Term Debt Noncurrent | $55.6M | $53.3M | $53.0M | $52.7M | $29.4M | $29.2M | ||
| Liabilities Current | $30.6M | $34.9M | $45.0M | $30.2M | $18.2M | $11.6M | ||
| Liabilities And Stockholders Equity | $190.6M | $217.1M | $251.9M | $159.0M | $140.8M | $41.8M | ||
| Liabilities | $103.2M | $104.2M | $114.0M | $98.5M | $47.7M | $41.0M | ||
| Inventory Net | $36.0M | $39.3M | $29.2M | $19.3M | $10.6M | $7.8M | ||
| Employee Related Liabilities Current | $6.3M | $6.6M | $7.5M | $7.7M | $4.5M | $2.2M | ||
| Assets Current | $132.1M | $161.4M | $198.4M | $133.4M | $138.0M | $41.0M | ||
| Assets | $190.6M | $217.1M | $251.9M | $159.0M | $140.8M | $41.8M | ||
| Allowance For Doubtful Accounts Receivable Current | $1.8M | $1.3M | $980.0K | $735.0K | $414.0K | $446.0K | ||
| Accrued Liabilities Current | $5.8M | $7.2M | $10.5M | $6.2M | $4.5M | $1.8M | ||
| Accrued Commissions | $9.4M | $10.1M | $10.8M | $7.4M | $5.2M | $3.5M | ||
| Accounts Payable Current | $6.7M | $10.5M | $11.8M | $8.7M | $4.1M | $2.3M | ||
| Non Cash Lease Expense | $2.2M | $2.3M | $2.5M | $2.5M | $0.00 | $0.00 | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$642.0K | -$1.6M | -$6.5M | -$86.4M | $87.8M | $5.9M | ||
| Operating Lease Right Of Use Asset | $7.6M | $8.4M | $9.3M | $10.1M | $1.9M | |||
| Other Assets Noncurrent | $1.2M | $407.0K | $146.0K | $146.0K | $0.00 | |||
| Operating Lease Liability Noncurrent | $14.0M | $15.9M | $15.9M | $15.5M | $0.00 | |||
| Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net | $694.0K | $992.0K | $1.3M | $635.0K | $811.0K | |||
| Common Stock Value | $64.0K | $62.0K | $62.0K | $55.0K | $45.0K | |||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Gains Losses On Extinguishment Of Debt | -$2.7M | $0.00 | $0.00 | -$4.5M | $0.00 | $0.00 | ||
| Accretion Amortization Of Discounts And Premiums Investments | $123.0K | $1.1M | $1.4M | $126.0K | $0.00 | $0.00 | ||
| Right Of Use Asset Obtained In Exchange For Operating Lease Incentive | $0.00 | $8.0K | -$22.0K | -$3.6M | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $89.2M | $97.6M | $105.3M | $104.9M | $112.1M | $126.4M | $137.9M | $150.0M | $157.6M | $62.2M | $71.7M | $86.8M | $97.4M | $102.9M | -$684.0K | -$2.5M | $79.0K | $1.8M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $7.7M | $8.1M | $13.4M | $12.1M | $18.2M | $9.3M | $7.3M | $12.0M | $29.6M | $88.5M | $101.5M | $98.5M | $109.5M | $119.6M | $16.2M | |||
| Cash And Cash Equivalents At Carrying Value | $7.7M | $8.1M | $13.4M | $12.1M | $18.2M | $9.3M | $7.3M | $12.0M | $29.6M | $88.5M | $101.5M | $98.5M | $109.5M | $119.6M | $16.2M | $15.4M | $10.3M | $10.6M |
| Marketable Securities Unrealized Gain Loss | $33.0K | -$7.0K | -$40.0K | $217.0K | -$95.0K | -$94.0K | $71.0K | -$163.0K | -$29.0K | $0.00 | $0.00 | $0.00 | ||||||
| Accounts Receivable Net Current | $33.0M | $30.3M | $31.1M | $24.2M | $25.6M | $30.1M | $25.0M | $27.2M | $25.4M | $18.5M | $16.5M | $16.0M | $11.8M | $10.0M | $10.8M | |||
| Retained Earnings Accumulated Deficit | -$239.6M | -$223.3M | -$205.9M | -$189.5M | -$174.1M | -$152.9M | -$128.0M | -$110.4M | -$98.2M | -$80.3M | -$68.2M | -$50.9M | -$35.3M | -$28.9M | -$23.8M | |||
| Property Plant And Equipment Net | $30.0M | $29.7M | $27.1M | $25.2M | $24.2M | $24.5M | $21.5M | $19.4M | $15.9M | $14.1M | $8.7M | $4.0M | $2.2M | $1.5M | $929.0K | |||
| Prepaid Expense And Other Assets Current | $6.2M | $5.6M | $4.3M | $7.0M | $9.7M | $11.4M | $10.7M | $5.3M | $4.6M | $4.0M | $4.0M | $1.7M | $3.8M | $3.5M | $2.1M | |||
| Long Term Debt Noncurrent | $53.5M | $53.5M | $53.4M | $53.2M | $53.2M | $53.1M | $52.9M | $52.9M | $52.8M | $52.6M | $52.6M | $29.4M | $29.3M | $29.3M | $29.2M | |||
| Liabilities Current | $40.9M | $41.9M | $33.2M | $38.3M | $44.4M | $47.0M | $33.2M | $30.0M | $23.3M | $22.6M | $16.6M | $15.4M | $10.7M | $9.9M | $8.6M | |||
| Liabilities And Stockholders Equity | $196.6M | $206.4M | $205.8M | $212.9M | $226.1M | $242.7M | $240.4M | $249.6M | $249.2M | $156.4M | $158.7M | $146.5M | $137.6M | $142.3M | $37.4M | |||
| Liabilities | $107.4M | $108.8M | $100.5M | $108.0M | $113.9M | $116.3M | $102.5M | $99.7M | $91.6M | $94.2M | $87.0M | $59.7M | $40.2M | $39.4M | $38.1M | |||
| Inventory Net | $41.4M | $42.4M | $37.9M | $43.6M | $41.3M | $35.9M | $29.3M | $26.1M | $22.5M | $16.8M | $13.2M | $11.1M | $10.4M | $7.6M | $7.4M | |||
| Employee Related Liabilities Current | $7.2M | $7.1M | $5.2M | $5.6M | $6.2M | $4.2M | $5.1M | $5.4M | $3.3M | $5.0M | $4.0M | $4.1M | $2.4M | $2.4M | $1.8M | |||
| Assets Current | $138.0M | $147.6M | $149.4M | $157.6M | $171.6M | $187.4M | $187.1M | $198.1M | $223.1M | $127.9M | $135.2M | $127.3M | $135.4M | $140.8M | $36.5M | |||
| Assets | $196.6M | $206.4M | $205.8M | $212.9M | $226.1M | $242.7M | $240.4M | $249.6M | $249.2M | $156.4M | $158.7M | $146.5M | $137.6M | $142.3M | $37.4M | |||
| Allowance For Doubtful Accounts Receivable Current | $1.5M | $1.6M | $1.4M | $743.0K | $978.0K | $1.1M | $639.0K | $707.0K | $677.0K | $423.0K | $430.0K | $509.0K | $282.0K | $271.0K | $329.0K | |||
| Accrued Liabilities Current | $7.3M | $6.2M | $6.0M | $8.1M | $13.7M | $15.2M | $8.9M | $7.1M | $8.0M | $5.2M | $4.8M | $3.6M | $2.8M | $2.0M | $2.8M | |||
| Accrued Commissions | $6.2M | $5.3M | $6.5M | $5.3M | $5.9M | $5.5M | $5.3M | $5.7M | $5.9M | $4.1M | $4.3M | $3.9M | $3.0M | $2.6M | $2.7M | |||
| Accounts Payable Current | $16.1M | $20.0M | $13.2M | $18.6M | $18.1M | $21.1M | $8.7M | $8.1M | $5.1M | $7.9M | $3.1M | $3.4M | $2.4M | $2.9M | $1.3M | |||
| Non Cash Lease Expense | $578.0K | $592.0K | $626.0K | $336.0K | $0.00 | |||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $2.0M | -$3.6M | $10.1M | -$7.4M | ||||||||||||||
| Operating Lease Right Of Use Asset | $7.8M | $8.0M | $8.2M | $8.6M | $8.8M | $9.1M | $9.5M | $9.7M | $9.9M | $14.2M | $14.7M | $15.1M | ||||||
| Other Assets Noncurrent | $614.0K | $676.0K | $387.0K | $458.0K | $146.0K | $146.0K | $146.0K | $146.0K | $215.0K | $146.0K | $134.0K | $134.0K | ||||||
| Operating Lease Liability Noncurrent | $12.9M | $13.4M | $13.9M | $16.5M | $16.3M | $16.2M | $16.4M | $16.8M | $15.4M | $19.0M | $17.8M | $14.8M | ||||||
| Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net | $769.0K | $843.0K | $917.0K | $1.1M | $1.1M | $1.2M | $1.4M | $1.4M | $590.0K | $679.0K | $723.0K | $767.0K | ||||||
| Common Stock Value | $64.0K | $63.0K | $63.0K | $62.0K | $62.0K | $62.0K | $62.0K | $62.0K | $61.0K | $46.0K | $46.0K | $46.0K | ||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| Gains Losses On Extinguishment Of Debt | $0.00 | $0.00 | $0.00 | $4.5M | $0.00 | $0.00 | ||||||||||||
| Accretion Amortization Of Discounts And Premiums Investments | $77.0K | $335.0K | $297.0K | $0.00 | ||||||||||||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Incentive | $0.00 | $35.0K | $0.00 |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $33.8M | $30.6M | $17.4M | $8.1M | $3.4M | $919.0K | $815.0K |
| Depreciation Depletion And Amortization | $10.6M | $8.4M | $5.4M | $2.1M | $685.0K | $1.2M | $793.0K |
| Share Based Compensation | $33.8M | $30.6M | $17.4M | $8.1M | $3.4M | $919.0K | $815.0K |
| Proceeds From Stock Options Exercised | $546.0K | $428.0K | $1.9M | $2.2M | $1.8M | $364.0K | $68.0K |
| Payments To Acquire Property Plant And Equipment | $13.5M | $11.6M | $11.5M | $14.8M | $2.7M | $1.1M | $1.2M |
| Net Cash Provided By Used In Operating Activities | -$16.0M | -$37.2M | -$34.6M | -$30.6M | -$17.2M | -$4.5M | -$7.7M |
| Net Cash Provided By Used In Investing Activities | $13.3M | $35.4M | -$81.3M | -$76.5M | -$2.7M | -$1.1M | -$1.2M |
| Net Cash Provided By Used In Financing Activities | $2.1M | $160.0K | $109.4M | $20.8M | $107.7M | $11.5M | $19.7M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$166.0K | -$2.2M | $1.2M | $668.0K | $2.4M | $103.0K | $94.0K |
| Increase Decrease In Inventories | -$3.2M | $10.0M | $9.8M | $8.8M | $2.7M | $2.3M | $2.8M |
| Increase Decrease In Accrued Liabilities | -$2.4M | -$7.9M | $7.5M | $7.1M | $6.6M | $1.1M | $3.9M |
| Increase Decrease In Accounts Receivable | $2.1M | $5.7M | $9.3M | $11.0M | $4.2M | $4.3M | $6.0M |
| Increase Decrease In Accounts Payable | -$3.8M | -$1.3M | $3.2M | $4.6M | $1.8M | $1.3M | -$236.0K |
| Increase Decrease In Other Noncurrent Assets | $503.0K | $330.0K | $0.00 | $146.0K | $0.00 | $0.00 | |
| Proceeds From Issuance Initial Public Offering | $0.00 | $0.00 | $107.5M | $0.00 | $107.6M | $0.00 | |
| Proceeds From Sale And Maturity Of Marketable Securities | $67.3M | $118.5M | $120.0M | $1.7M | $0.00 | $0.00 | |
| Increase Decrease In Operating Lease Liability | -$3.2M | -$2.5M | -$119.0K | $3.1M | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $8.0M | $9.6M | $8.7M | $7.9M | $6.7M | $7.4M | $5.2M | $3.6M | $2.7M | $2.3M | $2.0M | $1.4M | $839.0K | $875.0K | $402.0K | $125.0K | $248.0K | $209.0K |
| Depreciation Depletion And Amortization | $2.5M | $1.9M | $1.1M | $924.0K | $400.0K | $400.0K | $334.0K | $200.0K | $100.0K | $117.0K | $300.0K | $400.0K | $304.0K | |||||
| Share Based Compensation | $8.7M | $7.4M | $2.7M | $1.4M | $402.0K | $209.0K | ||||||||||||
| Proceeds From Stock Options Exercised | $119.0K | $52.0K | $352.0K | $1.4M | $569.0K | $41.0K | ||||||||||||
| Payments To Acquire Property Plant And Equipment | $3.5M | $3.9M | $1.5M | $1.5M | $196.0K | $674.0K | ||||||||||||
| Net Cash Provided By Used In Operating Activities | $4.2M | -$7.2M | -$17.3M | -$7.2M | -$446.0K | -$895.0K | ||||||||||||
| Net Cash Provided By Used In Investing Activities | -$1.9M | $3.8M | -$80.5M | -$1.5M | -$196.0K | -$674.0K | ||||||||||||
| Net Cash Provided By Used In Financing Activities | -$282.0K | -$185.0K | $107.9M | $1.4M | -$1.2M | $33.0K | ||||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$1.4M | $1.5M | $963.0K | -$1.2M | $379.0K | -$147.0K | ||||||||||||
| Increase Decrease In Inventories | -$1.3M | $6.6M | $3.2M | $551.0K | -$478.0K | $1.4M | ||||||||||||
| Increase Decrease In Accrued Liabilities | -$6.2M | -$6.9M | -$4.1M | -$2.6M | -$1.2M | -$4.1M | ||||||||||||
| Increase Decrease In Accounts Receivable | -$9.3M | -$7.8M | -$3.8M | -$2.5M | -$3.8M | -$3.8M | ||||||||||||
| Increase Decrease In Accounts Payable | $2.7M | $9.3M | -$3.6M | -$607.0K | -$1.2M | $1.5M | ||||||||||||
| Increase Decrease In Other Noncurrent Assets | $76.0K | $0.00 | -$69.0K | $134.0K | $0.00 | |||||||||||||
| Proceeds From Issuance Initial Public Offering | $0.00 | $107.5M | $0.00 | |||||||||||||||
| Proceeds From Sale And Maturity Of Marketable Securities | $16.7M | $36.4M | $20.5M | $0.00 | ||||||||||||||
| Increase Decrease In Operating Lease Liability | -$785.0K | -$657.0K | -$478.0K | -$133.0K | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.93 | -$0.90 | -$0.81 | -$0.77 | -$0.43 | -$0.12 | -$0.13 |
| Weighted Average Number Of Shares Outstanding Basic | 63.3M | 62.1M | 60.9M | 55.3M | 48.4M | 37.1M | |
| Weighted Average Number Of Diluted Shares Outstanding | 63.3M | 62.1M | 60.9M | 55.3M | 48.4M | 37.1M | |
| Earnings Per Share Basic | $-0.93 | $-0.90 | $-0.81 | $-0.77 | $-0.43 | $-0.12 | |
| Common Stock Shares Authorized | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | ||
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | ||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Common Stock Shares Issued | 64.0M | 62.4M | 61.7M | 55.6M | 54.2M | ||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.26 | -$0.28 | -$0.25 | -$0.25 | -$0.34 | -$0.30 | -$0.28 | -$0.20 | -$0.23 | -$0.22 | -$0.31 | -$0.16 | -$0.12 | -$0.10 | -$0.07 | -$0.08 | -$0.06 | -$0.05 |
| Weighted Average Number Of Shares Outstanding Basic | 63.5M | 63.0M | 62.7M | 62.2M | 62.1M | 61.8M | 61.6M | 61.4M | 58.7M | 55.4M | 55.3M | 54.8M | 52.8M | 49.2M | ||||
| Weighted Average Number Of Diluted Shares Outstanding | 63.5M | 63.0M | 62.7M | 62.2M | 62.1M | 61.8M | 61.6M | 61.4M | 58.7M | 55.4M | 55.3M | 54.8M | 52.8M | 49.2M | ||||
| Earnings Per Share Basic | $-0.26 | $-0.28 | $-0.25 | $-0.25 | $-0.34 | $-0.30 | $-0.28 | $-0.20 | $-0.23 | $-0.22 | $-0.31 | $-0.16 | $-0.12 | $-0.10 | ||||
| Common Stock Shares Authorized | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | ||||||
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | |||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| Common Stock Shares Issued | 63.8M | 63.1M | 63.0M | 62.3M | 62.2M | 61.9M | 61.6M | 61.5M | 61.3M | 55.5M | 55.4M | 55.3M | ||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stock Issued During Period Value Stock Options Exercised | $546.0K | $428.0K | $1.9M | $2.2M | $1.8M | $364.0K | $68.0K |
| Investment Income Net | $2.8M | $4.9M | $6.7M | $1.3M | $17.0K | -$1.7M | $111.0K |
| Provision For Doubtful Accounts | $2.9M | $434.0K | $411.0K | $144.0K | $216.0K | $145.0K | |
| Amortization Of Financing Costs | $292.0K | $298.0K | $297.0K | $244.0K | $176.0K | $220.0K | $147.0K |
| Additional Paid In Capital | $337.4M | $303.0M | $272.0M | $145.2M | $134.9M | $14.2M | |
| Other Operating Income Expense Net | $432.0K | $324.0K | $342.0K | -$403.0K | $1.0K | ||
| Interest Paid Net | $5.0M | $5.0M | $5.2M | $4.4M | $3.9M | $1.1M | $739.0K |
| Other Noncash Income Expense | -$1.2M | -$538.0K | -$205.0K | -$25.0K | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Issued During Period Value Stock Options Exercised | $241.0K | $116.0K | $119.0K | $8.0K | $311.0K | $52.0K | $159.0K | $1.2M | $352.0K | $353.0K | $165.0K | $1.4M | $41.0K | $193.0K | $570.0K | $41.0K | ||
| Investment Income Net | $634.0K | $775.0K | $841.0K | $1.1M | $1.4M | $1.5M | $1.6M | $2.0M | $1.5M | $420.0K | $131.0K | $9.0K | $5.0K | $6.0K | -$1.0K | -$1.8M | $3.0K | $33.0K |
| Provision For Doubtful Accounts | $500.0K | $159.0K | $38.0K | $30.0K | $0.00 | $0.00 | -$77.0K | $0.00 | -$200.0K | $73.0K | ||||||||
| Amortization Of Financing Costs | $74.0K | $75.0K | $74.0K | $45.0K | $43.0K | $65.0K | ||||||||||||
| Additional Paid In Capital | $329.7M | $321.5M | $311.8M | $294.4M | $286.5M | $279.4M | $265.9M | $260.6M | $255.8M | $142.5M | $139.8M | $137.7M | $132.6M | $131.7M | $15.1M | |||
| Other Operating Income Expense Net | $92.0K | $122.0K | $130.0K | $20.0K | $112.0K | $74.0K | $23.0K | $95.0K | $128.0K | -$45.0K | -$3.0K | $2.0K | ||||||
| Interest Paid Net | $1.2M | $1.3M | $1.3M | $951.0K | $1.9M | |||||||||||||
| Other Noncash Income Expense | -$187.0K | -$90.0K | $0.00 | $0.00 |
Most recent annual filing with the SEC: February 27, 2026
Data sourced from SEC EDGAR public filings as of August 4, 2026.